pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
STAT·Jun 10·1 min read
save

DOJ announces second settlement on youth gender-affirming care amid broader health news

Jun 10, 2026·read at STAT ↗RegulatoryNeutral

The Department of Justice disclosed that it has reached a second settlement with parties involved in providing gender-affirming care to minors. The agreement, announced in a recent newsletter, builds on a prior settlement and aims to address concerns raised by federal authorities.

Details of the settlement were not fully disclosed, but officials indicated it reflects ongoing scrutiny of youth gender-care practices and seeks to ensure compliance with applicable laws.

The same newsletter also highlighted other health-sector updates, including the appointment of a new acting director at the National Institute of Allergy and Infectious Diseases and a dispute at the American Diabetes Association meeting where five experts were escorted out after distributing an editorial criticizing federal research cuts.

source

This writeup was produced by pharmadog from original reporting by STAT.

Original headline: “DOJ reaches second settlement on youth gender care”

read at STAT ↗
1,142 words · retrieved Jun 10
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
The National Institute of Allergy and Infectious Diseases2Ultragenyx Pharmaceutical Inc.
drugs
SUBOXONE
topics
Type 2 Diabetes5Psychiatry & CNS2ApprovalCardiologyDermatologyDrug ShortageInfectious DiseaseRare Disease

related stories

  • Jun 2910 clinical trials to watch in the second half of 2026BioPharma Dive
  • 6d agoSTAT+: Pharmalittle: We’re reading about an AstraZeneca trial failure, a ‘monstrous’ conflict of interest, and moreSTAT
  • 18h agoNovartis may cut around 130 in Switzerland while relocating biologics productionBioSpace
  • Aug 27FDA Approves First Oral Drug Indicated to Treat Dermatomyositis in Adultsfda press
  • Aug 12STAT+: Pharmalittle: We’re reading about Lilly ‘black market’ lawsuits, pushback over Trump vaccine plan, and moreSTAT